Background: Due to mechanic stress, wear particles can be generated at the metal-to-metal interface of orthopedic implants [1]. These particles include polyethylene microplastics and titanium dioxide and can cause oxidative stress and cause inflammation through NLRP-3 dependent processes, comparable with monosodium urate crystals in gout [2]. Recognition and characterization of these particles can therefore be of clinical value in the treatment of implant related complications. Objectives: In this study we evaluate the microparticle content of synovial fluid from patients with suspected implant related complications using an integrated Raman spectroscope with an ordinary polarized light microscope. Methods: We retrieved 10 synovial fluid samples from patients with problematic prosthetic implants. In this study, only samples were chosen from patients who had a clinical suspicion of complications of their prosthetic joint (i.e., a painful, warm and/or swollen prosthetic joint). We analyzed the presence or absence and the nature of microparticles in the samples with iRPolM. Results: Table 1 shows the results of Raman spectroscopic analyses of the 10 included samples. Titanium dioxide particles were present in 90%, microplastics were present in 80% of the samples. Patients 1 till 7 were positive for bacteria after culture, indicating a microbial infection. All patients were positive for pro-inflammatory particles in their synovial fluid and there was no difference between patients with and without signs of bacterial infection. Conclusion: Raman spectroscopy can be of additional value to physicians in cases with problematic implants and swollen joints. Analysis demonstrates a ubiquitous presence of titanium dioxide and microplastics in the periprosthetic synovium. As these microparticles have been proven to be pro-inflammatory through NLRP-3 dependent processes, these patients might benefit from inflammasome-inhibitory therapies. Therefore, Raman spectroscopy can aid in the guidance on therapeutic options for non-microbial implant related complications. REFERENCES: [1] Yao, J.J., E.A. Lewallen, W.H. Trousdale, W. Xu, R. Thaler, C.G. Salib, et al., Local Cellular Responses to Titanium Dioxide from Orthopedic Implants. BioResearch open access, 2017. 6(1): p. 94-103. [2] Ruiz, P.A., B. Morón, H.M. Becker, S. Lang, K. Atrott, M.R. Spalinger, et al., Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut, 2017. 66(7): p. 1216-1224. Acknowledgements: Jan Maarten van Dijk, Marjan Wouthuyzen-Bakker. Disclosure of Interests: Tom Niessink: None declared, Jorrit Schoenmakers: None declared, Matthijs Janssen Crystalytics B.V., Cees Otto Hybriscan Technologies B.V., Tim Jansen Crystalytics B.V.
No takes yet. Share an insight, caveat, or question.
Niessink et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: